Literature DB >> 16107154

Inhibition of carboxylesterases by benzil (diphenylethane-1,2-dione) and heterocyclic analogues is dependent upon the aromaticity of the ring and the flexibility of the dione moiety.

Janice L Hyatt1, Vanessa Stacy, Randy M Wadkins, Kyoung Jin P Yoon, Monika Wierdl, Carol C Edwards, Matthias Zeller, Allen D Hunter, Mary K Danks, Guy Crundwell, Philip M Potter.   

Abstract

Benzil has been identified as a potent selective inhibitor of carboxylesterases (CEs). Essential components of the molecule required for inhibitory activity include the dione moiety and the benzene rings, and substitution within the rings affords increased selectivity toward CEs from different species. Replacement of the benzene rings with heterocyclic substituents increased the K(i) values for the compounds toward three mammalian CEs when using o-nitrophenyl acetate as a substrate. Logarithmic plots of the K(i) values versus the empirical resonance energy, the heat of union of formation energy, or the aromatic stabilization energy determined from molecular orbital calculations for the ring structures yielded linear relationships that allowed prediction of the efficacy of the diones toward CE inhibition. Using these data, we predicted that 2,2'-naphthil would be an excellent inhibitor of mammalian CEs. This was demonstrated to be correct with a K(i) value of 1 nM being observed for a rabbit liver CE. In addition, molecular simulations of the movement of the ring structures around the dione dihedral indicated that the ability of the compounds to inhibit CEs was due, in part, to rotational constraints enforced by the dione moiety. Overall, these studies identify subdomains within the aromatic ethane-1,2-diones, that are responsible for CE inhibition.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16107154     DOI: 10.1021/jm0504196

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  20 in total

1.  Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin.

Authors:  M J Hatfield; L Tsurkan; J L Hyatt; X Yu; C C Edwards; L D Hicks; R M Wadkins; P M Potter
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Latent blue and red fluorophores based on the trimethyl lock.

Authors:  Luke D Lavis; Tzu-Yuan Chao; Ronald T Raines
Journal:  Chembiochem       Date:  2006-08       Impact factor: 3.164

Review 3.  Carboxylesterase inhibitors.

Authors:  M Jason Hatfield; Philip M Potter
Journal:  Expert Opin Ther Pat       Date:  2011-05-24       Impact factor: 6.674

4.  Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones.

Authors:  Elizabeth I Parkinson; M Jason Hatfield; Lyudmila Tsurkan; Janice L Hyatt; Carol C Edwards; Latorya D Hicks; Bing Yan; Philip M Potter
Journal:  Bioorg Med Chem       Date:  2011-07-04       Impact factor: 3.641

Review 5.  Challenges and Opportunities with Non-CYP Enzymes Aldehyde Oxidase, Carboxylesterase, and UDP-Glucuronosyltransferase: Focus on Reaction Phenotyping and Prediction of Human Clearance.

Authors:  Upendra A Argikar; Philip M Potter; J Matthew Hutzler; Punit H Marathe
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

6.  Global and local molecular dynamics of a bacterial carboxylesterase provide insight into its catalytic mechanism.

Authors:  Xiaozhen Yu; Sara C Sigler; Delwar Hossain; Monika Wierdl; Steven R Gwaltney; Philip M Potter; Randy M Wadkins
Journal:  J Mol Model       Date:  2011-11-30       Impact factor: 1.810

7.  Inhibition of carboxylesterase 1 is associated with cholesteryl ester retention in human THP-1 monocyte/macrophages.

Authors:  J Allen Crow; Brandy L Middleton; Abdolsamad Borazjani; M Jason Hatfield; Philip M Potter; Matthew K Ross
Journal:  Biochim Biophys Acta       Date:  2008-08-05

8.  Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").

Authors:  M Jason Hatfield; Lyudmila G Tsurkan; Janice L Hyatt; Carol C Edwards; Andrew Lemoff; Cynthia Jeffries; Bing Yan; Philip M Potter
Journal:  J Nat Prod       Date:  2013-01-03       Impact factor: 4.050

9.  Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.

Authors:  Latorya D Hicks; Janice L Hyatt; Shana Stoddard; Lyudmila Tsurkan; Carol C Edwards; Randy M Wadkins; Philip M Potter
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

10.  Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils.

Authors:  Latorya D Hicks; Janice L Hyatt; Teri Moak; Carol C Edwards; Lyudmila Tsurkan; Monika Wierdl; Antonio M Ferreira; Randy M Wadkins; Philip M Potter
Journal:  Bioorg Med Chem       Date:  2007-03-12       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.